Conclusions
CDA, COLD
In this RCT, we did not find evidence that a combined drug approach targeting the post–cold storage graft and the recipient was sufficient to decrease IRI. Targeting the graft before and/or during preservation may also be necessary. The advent of dynamic preservation may bring the opportunity to combine a downstream CDA in the recipient with upstream conditioning of the donor liver.